Skip to main content

Ellen Moholt

Spesialsykepleier

ORCID: 0000-0002-4987-4863

Utdanning

  • Sykepleierutdanning, Betanien Sykepleierhøyskole 1985 - 1988
  • Master i klinisk sykepleier, Høyskolen Gjøvik, NTNU, 2012 - 2015
  • NorCRIN – Nasjonalt kurs i studiesykepleie, 2022
  • Sertifisert DXA-operatør, 2022

Stilling

  • Spesialsykepleier/studiesykepleier

Interessefelt

  • Sykepleie til mennesker med revmatisk sykdom
  • RA, PsA, SPA
  • Osteoporose
  • Smerte

E-post

Denne e-postadressen er beskyttet mot programmer som samler e-postadresser. Du må aktivere javaskript for å kunne se den.

Telefon

22454936
22454298
93031842

Besøksadresse

Diakonhjemmet sykehus
Diakonveien 12
0370 Oslo

Postadresse

Diakohjemmet sykehus
Postboks 23 Vinderen
0319 Oslo

Prosjekter

WP1 - Behandlingsstudier

MethMax

Maksimalisering av behandlingseffekt

Prosjektleder:
Siri Lillegraven
WP6 - Langtidsoppfølging

NOR-DMARD

Det norske registeret for antirevmatiske legemidler

Prosjektleder:
Tore K. Kvien
WP5 - Strategier for digital oppfølging

NOR-Flare

Avstandsoppfølging av pasienter med revmatoid artritt

Prosjektleder:
Anne Therese Tveter
WP1 - Behandlingsstudier

NOR-Sprint

Oppfølging av nydiagnostiserte pasienter med psoriasisartritt med og uten bildediagnostikk

Prosjektleder:
Siri Lillegraven
WP1 - Behandlingsstudier

RA-DRUM

Terapeutisk legemiddelmonitorering hos pasienter med revmatoid artritt (RA-DRUM)

Prosjektleder:
Silje Watterdal Syversen

Publikasjoner

Publikasjoner hentet fra Nasjonalt vitenarkiv (NVA):

Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial

Kaja Eriksrud Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad


The Lancet Rheumatology

2024

Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

Simon Décary, Maarten De Wit, Florian Naye, Jennifer L. Barton, Liana Fraenkel, Linda C. Li


Seminars in Arthritis & Rheumatism

2024

Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial

Inger Jorid Berg, Anne Therese Tveter, Gunnstein Bakland, Sarah Hakim, Eirik Kristianslund, Siri Lillegraven


JMIR Research Protocols

2023

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial

Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Lexberg


Annals of the Rheumatic Diseases

2023

Educational readiness among health professionals in rheumatology: low awareness of EULAR offerings and unfamiliarity with the course content as major barriers-results of a EULAR-funded European survey

Valentin Ritschl, Lisa Sperl, Margaret Renn Andrews, Mathilda Björk, Carina Boström, Jeannette Cappon


RMD Open

2023

Use of video consultations in an outpatient rheumatology clinic

Anne Therese Tveter, Sella Aarrestad Provan, Ellen Moholt, Kjetil Bergsmark, Nina Østerås


Tidsskrift for Den norske legeforening

2021

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

Karen Holten, Nina Beate Paulshus Sundlisæter, Siri Lillegraven, Joseph Sexton, Lena Kristine Bugge Nordberg, Ellen Moholt


Annals of the Rheumatic Diseases

2021

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach

Karine Toupin-April, Simon Décary, Maarten de Wit, Alexa Meara, Jennifer L. Barton, Liana Fraenkel


Seminars in Arthritis & Rheumatism

2021

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients with Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial

Siri Lillegraven, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad


Journal of the American Medical Association (JAMA)

2021

2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice

Valentin Ritschl, Tanja Stamm, Daniel Aletaha, Hans Bijlsma, Peter Böhm, Răzvan Gabriel Drăgoi


Annals of the Rheumatic Diseases

2020

Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider

Valentin Ritschl, Tanja Stamm, Daniel Aletaha, Hans Bijlsma, Peter Böhm, Răzvan Gabriel Drăgoi


RMD Open

2020

NOR-DMARD data management: implementation of data capture from electronic health records

Inge Christoffer Olsen, Espen A. Haavardsholm, Ellen Moholt, Tore Kristian Kvien, Elisabeth Lie


Clinical and Experimental Rheumatology

2014